X4 Pharmaceuticals (XFOR) Net Shares Issued and Repurchased (2018 - 2019)
X4 Pharmaceuticals' (XFOR) quarterly Net Shares Issued and Repurchased came in at $136913.0 in Q1 2019, down 80.52% on a YoY basis from $703000.0 in Q1 2018, and down 83.49% quarter-over-quarter from $829500.0 in Q4 2018.
Powered by 
Analysis
X4 Pharmaceuticals (XFOR) Net Shares Issued and Repurchased (2018 - 2019) Analysis & Trends
X4 Pharmaceuticals (XFOR) has reported Net Shares Issued and Repurchased for 2 consecutive years, with $136913.0 the latest figure, recorded in Q1 2019.
- For the quarter ending Q1 2019, Net Shares Issued and Repurchased fell 80.52% year-over-year to $136913.0; the trailing twelve-month figure through Mar 2019 stood at $136913.0 (down 80.52% YoY), and the FY2018 full-year result was $829500.0, changed N/A from the prior year.
- Net Shares Issued and Repurchased fell to $136913.0 in Q1 2019 per XFOR's latest filing, from $829500.0 in the prior quarter.
- Across five years, Net Shares Issued and Repurchased topped out at $829500.0 in Q4 2018 and bottomed at $136913.0 in Q1 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | - |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | - |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | -3.07 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | - |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | BeOne Medicines | 40.49 Bn | 35.39 Bn | 1.53 Bn | - |
| 9 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | - |
| 10 | X4 Pharmaceuticals | 510.43 Mn | 315.33 Mn | 7.19 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2019 | 136,913.00 |
| Dec 31, 2018 | 829,500.00 |
| Mar 31, 2018 | 703,000.00 |